Mucosal organs such as the intestine are supported by a rich and complex underlying vasculature. For this reason, the intestine, and particularly barrier-protective epithelial cells, are susceptible to damage related to diminished blood flow and concomitant tissue hypoxia. We sought to identify compensatory mechanisms that protect epithelial barrier during episodes of intestinal hypoxia. Initial studies examining T84 colonic epithelial cells revealed that barrier function is uniquely resistant to changes elicited by hypoxia. A search for intestinal-specific, barrier-protective factors revealed that the human intestinal trefoil factor (ITF) gene promoter bears a previously unappreciated binding site for hypoxia-inducible factor (HIF)-1. Hypoxia resulted in parallel induction of ITF mRNA and protein. Electrophoretic mobility shift assay analysis using ITF-specific, HIF-1 consensus motifs resulted in a hypoxia-inducible DNA binding activity, and loading cells with antisense oligonucleotides directed against the α chain of HIF-1 resulted in a loss of ITF hypoxia inducibility. Moreover, addition of anti-ITF antibody resulted in a loss of barrier function in epithelial cells exposed to hypoxia, and the addition of recombinant human ITF to vascular endothelial cells partially protected endothelial cells from hypoxia-elicited barrier disruption. Extensions of these studies in vivo revealed prominent hypoxia-elicited increases in intestinal permeability in ITF null mice. HIF-1–dependent induction of ITF may provide an adaptive link for maintenance of barrier function during hypoxia.
Skip Nav Destination
Article navigation
7 May 2001
Article|
April 30 2001
Hypoxia-Inducible Factor 1–Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia
Glenn T. Furuta,
Glenn T. Furuta
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
cCombined Program for Pediatric Gastroenterology and Nutrition, Children's Hospital,
Search for other works by this author on:
Jerrold R. Turner,
Jerrold R. Turner
eDepartment of Pathology, Wayne State University, Detroit, Michigan 48201
Search for other works by this author on:
Cormac T. Taylor,
Cormac T. Taylor
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
Search for other works by this author on:
Robert M. Hershberg,
Robert M. Hershberg
bDivision of Gastroenterology, Brigham and Women's Hospital, the
Search for other works by this author on:
Katrina Comerford,
Katrina Comerford
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
Search for other works by this author on:
Sailaja Narravula,
Sailaja Narravula
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
Search for other works by this author on:
Daniel K. Podolsky,
Daniel K. Podolsky
dGastrointestinal Unit and Center for Study of Inflammatory Bowel Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Sean P. Colgan
Sean P. Colgan
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
Search for other works by this author on:
Glenn T. Furuta
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
cCombined Program for Pediatric Gastroenterology and Nutrition, Children's Hospital,
Jerrold R. Turner
eDepartment of Pathology, Wayne State University, Detroit, Michigan 48201
Cormac T. Taylor
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
Robert M. Hershberg
bDivision of Gastroenterology, Brigham and Women's Hospital, the
Katrina Comerford
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
Sailaja Narravula
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
Daniel K. Podolsky
dGastrointestinal Unit and Center for Study of Inflammatory Bowel Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02115
Sean P. Colgan
aCenter for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, the
Abbreviations used in this paper: EMSA, electrophoretic mobility shift assay; EPO, erythropoietin; HIF, hypoxia-inducible factor; HRE, hypoxic response element; ITF, intestinal trefoil factor; MDCK, Madin-Darby canine kidney; MVEC, microvascular endothelial cell; RT, reverse transcription.
Received:
July 18 2000
Revision Requested:
February 08 2001
Accepted:
March 26 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 193 (9): 1027–1034.
Article history
Received:
July 18 2000
Revision Requested:
February 08 2001
Accepted:
March 26 2001
Citation
Glenn T. Furuta, Jerrold R. Turner, Cormac T. Taylor, Robert M. Hershberg, Katrina Comerford, Sailaja Narravula, Daniel K. Podolsky, Sean P. Colgan; Hypoxia-Inducible Factor 1–Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia. J Exp Med 7 May 2001; 193 (9): 1027–1034. doi: https://doi.org/10.1084/jem.193.9.1027
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement